Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Jun 10

PMID 35683611

Authors

Ilias N Migdalis

Ioannis M Ioannidis

Nikolaos Papanas

Athanasios E Raptis

Alexios E Sotiropoulos

George D Dimitriadis

The Hellenic Diabetic Nephropathy Study Hdns

Affiliations

Soon will be listed here.

Abstract

Aims/introduction: Several reports indicate an increasing prevalence of chronic kidney disease (CKD) in type 2 diabetes mellitus (T2DM). Hyperglycemia and hypertension are the main risk factors for CKD development and progression. However, despite the achievement of recommended targets for blood glucose and blood pressure (BP), the residual risk of diabetic chronic kidney disease (DCKD) remains relatively high. The aim of this study is to examine dyslipidemia and other major risk factors to provide support for the prevention and treatment of DCKD.

Materials And Methods: Participants are from the Redit-2-Diag study that examines 1759 subjects within a period of 6 months. DCKD severity is staged according to KDIGO criteria.

Results: An increase in hemoglobin A (1 unit) and systolic blood pressure (1 mm Hg) increases the probability of being classified into a higher CKD stage by 14% and 26%, respectively. Moreover, an increase of triglycerides by 88.5 mg/dL increases the risk of classification to a worse CKD stage by 24%.

Conclusions: Elevated triglycerides, systolic blood pressure, and poor glycemic control increase the risk of CKD in T2DM and should be addressed in the treatment strategies.

Citing Articles

Genetic and clinical characteristics of patients with lipoprotein lipase deficiency from Slovenia and Pakistan: case series and systematic literature review.

Ain Q, Cevc M, Marusic T, Sikonja J, Sadiq F, Sustar U Front Endocrinol (Lausanne). 2024; 15:1387419.

PMID: 38911039 PMC: 11190153. DOI: 10.3389/fendo.2024.1387419.

Association of urinary albumin-to-creatinine ratio with lipid abnormalities and glycemic control in patients with type 2 diabetes mellitus.

Khadka S, Yadav G, Subedi P, Amgain K, Sharma A, Joshi R Ann Med Surg (Lond). 2023; 85(9):4329-4333.

PMID: 37663740 PMC: 10473380. DOI: 10.1097/MS9.0000000000001045.

References

Lin J, Hu F, Rimm E, Rifai N, Curhan G . The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int. 2006; 69(2):336-42. PMC: 1630638. DOI: 10.1038/sj.ki.5000021. View

Cusick M, Chew E, Hoogwerf B, Agron E, Wu L, Lindley A . Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26. Kidney Int. 2004; 66(3):1173-9. DOI: 10.1111/j.1523-1755.2004.00869.x. View

Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Himmelfarb C . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on.... J Am Coll Cardiol. 2017; 71(19):e127-e248. DOI: 10.1016/j.jacc.2017.11.006. View

Bowe B, Xie Y, Xian H, Balasubramanian S, Al-Aly Z . Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. Kidney Int. 2016; 89(4):886-96. DOI: 10.1016/j.kint.2015.12.034. View

Lamprea-Montealegre J, Staplin N, Herrington W, Haynes R, Emberson J, Baigent C . Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD. Clin J Am Soc Nephrol. 2019; 15(1):47-60. PMC: 6946066. DOI: 10.2215/CJN.07320619. View

De Cosmo S, Menzaghi C, Prudente S, Trischitta V . Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant. 2012; 28(1):29-36. DOI: 10.1093/ndt/gfs290. View

Mallik R, Chowdhury T . Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future. Ther Adv Endocrinol Metab. 2022; 13:20420188221081601. PMC: 8905210. DOI: 10.1177/20420188221081601. View

Le Roith D, Zick Y . Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care. 2001; 24(3):588-97. DOI: 10.2337/diacare.24.3.588. View

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

10.

Hu F, Zhang T . Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus. Int J Gen Med. 2020; 13:351-360. PMC: 7352450. DOI: 10.2147/IJGM.S255858. View

11.

. 11. Microvascular Complications and Foot Care: . Diabetes Care. 2020; 44(Suppl 1):S151-S167. DOI: 10.2337/dc21-S011. View

12.

Muntner P, Coresh J, Smith J, Eckfeldt J, Klag M . Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000; 58(1):293-301. DOI: 10.1046/j.1523-1755.2000.00165.x. View

13.

Matsushita K, Kwak L, Ballew S, Grams M, Selvin E, Folsom A . Chronic kidney disease measures and the risk of abdominal aortic aneurysm. Atherosclerosis. 2018; 279:107-113. PMC: 6295219. DOI: 10.1016/j.atherosclerosis.2018.08.043. View

14.

Griffin T, OShea P, Smyth A, Islam M, Wall D, Ferguson J . Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe. BMJ Open Diabetes Res Care. 2023; 9(1). PMC: 8204173. DOI: 10.1136/bmjdrc-2021-002125. View

15.

Steinberg D, Witztum J . Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010; 30(12):2311-6. DOI: 10.1161/ATVBAHA.108.179697. View

16.

Cheung A, Chang T, Cushman W, Furth S, Ix J, Pecoits-Filho R . Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019; 95(5):1027-1036. DOI: 10.1016/j.kint.2018.12.025. View

17.

Major R, Cheng M, Grant R, Shantikumar S, Xu G, Oozeerally I . Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One. 2018; 13(3):e0192895. PMC: 5862400. DOI: 10.1371/journal.pone.0192895. View

18.

Wang C, Wang L, Liang K, Yan F, Hou X, Liu F . Poor Control of Plasma Triglycerides Is Associated with Early Decline of Estimated Glomerular Filtration Rates in New-Onset Type 2 Diabetes in China: Results from a 3-Year Follow-Up Study. J Diabetes Res. 2020; 2020:3613041. PMC: 7542506. DOI: 10.1155/2020/3613041. View

19.

Fioretto P, Dodson P, Ziegler D, Rosenson R . Residual microvascular risk in diabetes: unmet needs and future directions. Nat Rev Endocrinol. 2009; 6(1):19-25. DOI: 10.1038/nrendo.2009.213. View

20.

Dimitriadis G, Boutati E, Lambadiari V, Mitrou P, Maratou E, Brunel P . Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism. Eur J Clin Invest. 2004; 34(7):490-7. DOI: 10.1111/j.1365-2362.2004.01377.x. View